Routine CBC and CMP Screening in Healthy Teenagers
In healthy teenagers without chronic illness, routine CBC and CMP testing at well-child visits is not recommended. There are no evidence-based guidelines supporting universal laboratory screening in this population during routine preventive care.
Key Guideline Recommendations
The most authoritative guidance comes from the American Academy of Pediatrics (AAP) 2016 Bright Futures Periodicity Schedule 1, which does not include routine CBC or CMP testing for healthy adolescents at well-child visits. The AAP recommendations focus on:
- Anemia screening: Universal hemoglobin/hematocrit at 12 months of age, with risk-based assessment at 15 and 30 months 1
- Dyslipidemia screening: One-time lipid screening at 9-11 years of age (due to obesity epidemic) 1
- Blood pressure: Annual measurement starting at age 3 years 2
Notably absent from these recommendations is any routine CBC or comprehensive metabolic panel testing for healthy adolescents.
Disease-Specific Exceptions
Laboratory monitoring is only recommended when specific chronic conditions exist:
For Adolescents with Diabetes (Type 1 or Type 2)
- Lipid panel: Initially after diagnosis (age ≥2 years), then every 3 years if LDL <100 mg/dL 3, 4
- Thyroid function: TSH at diagnosis, then every 1-2 years 3, 4
- Kidney function: Annual albumin-to-creatinine ratio starting at puberty or ≥11 years with 3-5 years diabetes duration 4
For Adolescents on Specific Medications
- NSAIDs (chronic daily use): CBC, liver function tests, and renal function every 6-12 months 5, 6
- Methotrexate: CBC, liver function tests, and renal function within 1-2 months of starting, then every 3-4 months 5, 6
- Antipsychotics: Monitoring varies by agent; clozapine requires weekly CBC for 6 months, then biweekly 7
For Adolescents with Hypertension
Blood pressure should be checked at every visit (not annually) if the teenager has obesity, renal disease, diabetes, or is on medications that increase blood pressure 2, 3.
Clinical Reasoning
The absence of routine screening recommendations reflects several important principles:
Low yield in asymptomatic patients: Research demonstrates that routine laboratory testing in healthy children has minimal clinical utility and can lead to unnecessary follow-up testing and patient anxiety 8, 9
Cost considerations: Studies show potential cost savings when limiting testing to clinically indicated scenarios, with one pediatric emergency department study demonstrating $7,125 in potential annual savings by avoiding unnecessary comprehensive metabolic panels 9
Risk of overdiagnosis: Unnecessary testing can lead to false positives, additional testing, and potential harm from overtreatment
Practical Approach
For a truly healthy teenager at a well-child visit:
- No CBC or CMP is needed
- Perform annual blood pressure measurement
- Consider one-time lipid screening at age 9-11 years (if not already done)
- Screen for HIV at age 16-18 years 1
Red flags that would prompt laboratory testing:
- Symptoms suggesting anemia (fatigue, pallor, exercise intolerance)
- Signs of metabolic disease (polyuria, polydipsia, unexplained weight changes)
- Abnormal physical examination findings
- Family history of inherited blood disorders or metabolic conditions
- Obesity with metabolic syndrome features
- Chronic medication use requiring monitoring
Common Pitfalls to Avoid
- Don't order "routine labs" reflexively: The CBC and CMP are not part of standard preventive care for healthy adolescents
- Don't confuse adult screening with pediatric screening: Many adult preventive guidelines do not apply to teenagers
- Don't assume more testing equals better care: Unnecessary testing can lead to cascades of additional testing and anxiety without improving outcomes
The evidence is clear: healthy teenagers without chronic conditions or concerning symptoms do not require routine CBC or CMP testing at well-child visits. Laboratory testing should be reserved for specific clinical indications, chronic disease monitoring, or medication surveillance.